Evidence map›Paper›PMID 29404083›Full record

ReviewTurkish thoracic journal2015

Updates in Chronic Obstructive Pulmonary Disease for the Year 2014.

Sibel Atış Naycı, Lütfi Çöplü, Alev Gürgün, Nurdan Köktürk, Mehmet Polatlı, Elif Şen, Sema Umut, Esra Uzaslan, Nurhayat Yıldırım, Peter J Barnes

Erratum issuedAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Turkish thoracic journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Sibel Atış NaycıDepartment of Pulmonology, Mersin University Faculty of Medicine, Mersin, Turkey.
Lütfi ÇöplüDepartment of Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Alev GürgünDepartment of Pulmonology, Ege University Faculty of Medicine, İzmir, Turkey.
Nurdan KöktürkDepartment of Pulmonology, Gazi University Faculty of Medicine, Ankara, Turkey.
Mehmet PolatlıDepartment of Pulmonology, Adnan Menderes University Faculty of Medicine, Aydın, Turkey.
Elif ŞenDepartment of Pulmonology, Ankara University, Faculty of Medicine, Pulmonology, Ankara, Turkey.
Sema UmutDepartment of Pulmonology, İstanbul University, Faculty of Medicine, Pulmonology, İstanbul, Turkey.
Esra UzaslanDepartment of Pulmonology, Uludağ University, Faculty of Medicine, Pulmonology, Bursa, Turkey.
Nurhayat YıldırımDepartment of Pulmonology, İstanbul University, Faculty of Medicine, Pulmonology, İstanbul, Turkey.
Peter J BarnesNational Heart and Lung Institute, Airway Disease, Airway Disease, London, England.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality in the world. Research conducted over the past decade has contributed much to our current knowledge of the pathogenesis and treatment of COPD. Additionally, an evolving literature has recently accumulated information about the management of COPD and also about exacerbations. This article reviews a concise summary on the updates in COPD including 1) new pathogenic mechanisms and therapeutic targets, 2) management of patients in Group B, C and D according to GOLD 2014 report; 3) prevention and management of exacerbation; 4) monitoring of natural history; and 5) essential but usually forgotten parts of the management.

Indexed as

COPDdisease managementexacerbationnatural history

Identifiers

PMID29404083
PMCPMC5783065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.